MUC1 Limits Helicobacter pylori Infection both by Steric Hindrance and by Acting as a Releasable Decoy by Lindén, Sara K. et al.
MUC1 Limits Helicobacter pylori Infection both by Steric
Hindrance and by Acting as a Releasable Decoy
Sara K. Linde ´n
1,2*, Yong H. Sheng
1, Alison L. Every
3, Kim M. Miles
1, Emma C. Skoog
2, Timothy H. J.
Florin
1,4, Philip Sutton
3, Michael A. McGuckin
1*
1Mucosal Diseases Program, Mater Medical Research Institute, Mater Health Services, South Brisbane, Queensland, Australia, 2Mucosal Immunobiology and Vaccine
Center, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden, 3Centre for Animal Biotechnology, School of Veterinary Science, University of Melbourne,
Melbourne, Victoria, Australia, 4Department of Medicine, University of Queensland, Queensland, Australia
Abstract
The bacterium Helicobacter pylori can cause peptic ulcer disease, gastric adenocarcinoma and MALT lymphoma. The cell-
surface mucin MUC1 is a large glycoprotein which is highly expressed on the mucosal surface and limits the density of H.
pylori in a murine infection model. We now demonstrate that by using the BabA and SabA adhesins, H. pylori bind MUC1
isolated from human gastric cells and MUC1 shed into gastric juice. Both H. pylori carrying these adhesins, and beads coated
with MUC1 antibodies, induced shedding of MUC1 from MKN7 human gastric epithelial cells, and shed MUC1 was found
bound to H. pylori. Shedding of MUC1 from non-infected cells was not mediated by the known MUC1 sheddases ADAM17
and MMP-14. However, knockdown of MMP-14 partially affected MUC1 release early in infection, whereas ADAM17 had no
effect. Thus, it is likely that shedding is mediated both by proteases and by disassociation of the non-covalent interaction
between the a- and b-subunits. H. pylori bound more readily to MUC1 depleted cells even when the bacteria lacked the
BabA and SabA adhesins, showing that MUC1 inhibits attachment even when bacteria cannot bind to the mucin. Bacteria
lacking both the BabA and SabA adhesins caused less apoptosis in MKN7 cells than wild-type bacteria, having a greater
effect than deletion of the CagA pathogenicity gene. Deficiency of MUC1/Muc1 resulted in increased epithelial cell
apoptosis, both in MKN7 cells in vitro, and in H. pylori infected mice. Thus, MUC1 protects the epithelium from non-MUC1
binding bacteria by inhibiting adhesion to the cell surface by steric hindrance, and from MUC1-binding bacteria by acting as
a releasable decoy.
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Introduction
The bacterium Helicobacter pylori can cause peptic ulcer disease,
gastric adenocarcinoma and MALT lymphoma [1]. H. pylori is
estimated to cause approximately70% of all gastric cancers,and gastric
cancer is the second most common cause of cancer related deaths. H.
pylori infection and the H. pylori induced pathologies, chronic atrophic
gastritis and gastric cancer, are all associated with an increase in
epithelial apoptosis [2,3,4]. One mechanism by which H. pylori can
induce apoptosis is by the delivery of the protein CagA into epithelial
cells by a type IV secretion system [5,6]. This process subsequently
activates multiple intracellular signaling cascades inducing an apoptotic
response [5,6] that has been suggested to promote gastric carcinogen-
esis by a compensatory increase in gastric epithelial cell proliferation
[4]. Supporting this notion, there are more proliferating cells in
inflamed mucosa under H. pylori infestation than in H. pylori free areas
of the mucosa [7]. Furthermore, it has been shown that in response to
chronic Helicobacter felis infection in mice, bone marrow–derived cells
can home to and repopulate the gastric mucosa, replacing dead or
exhausted epithelial stem cells and contribute over time to metaplasia,
dysplasia, and cancer [8].
Adherence of some H. pylori to the mucosal surface is likely to
help the bacterial population remain in the neutral and protected
niche under the mucus layer, and help it withstand the continuous
mucus washing of the mucosal surface. Adherence of H. pylori is
dependent on the expression of bacterial adhesins and cognate
host glycans, displayed by glycoproteins and glycosphingolipids in
gastric epithelium and also by mucins in the gastric mucus layer
[9,10,11]. Several adhesins have been implicated in H. pylori
binding: the Blood group Antigen Binding Adhesin (BabA) binds
to the fucosylated ABO/Lewis b antigen (Le
b), and the Sialic Acid
Binding Adhesin (SabA) binds to the sialyl-Lewis x (sLe
x) and
sialyl-Lewis a antigens (sLe
a) [12,13]. In the human stomach, the
Le
b blood-group antigen is mainly expressed by the surface
epithelium and on the MUC5AC secreted mucin [11]. Expression
of sialylated Le antigens are common in infected and inflamed
gastric mucosa [14,15,16].
Under the mucus layer, the cell-surface associated mucins are
highly expressed glycoproteins on the apical surface of all mucosal
epithelial cells. Because of their long filamentous nature, cell
surface mucins are likely to be the first point of direct contact
between host tissue and organisms that penetrate the secreted
PLoS Pathogens | www.plospathogens.org 1 October 2009 | Volume 5 | Issue 10 | e1000617mucus layer. MUC1 is the most highly expressed cell surface
mucin in the stomach [17]. Most mucins exhibit considerable
genetic polymorphism due to variability in their numbers of
tandem repeat peptides, which results in proteins of widely
divergent lengths. Several studies have linked MUC1 polymor-
phisms with susceptibility to H. pylori-induced disease, such as
gastritis and gastric cancer [18,19], suggesting a direct effect of
MUC1 polymorphisms on the development of Helicobacter-associ-
ated pathology. We have shown that mice deficient in Muc1 are
more susceptible to infection by both H. pylori [20] and
Campylobacter jejuni [21]. However, the mechanism by which this
mucin limits bacterial pathogenesis has not been elucidated. In this
study, we have characterized mechanisms by which MUC1 limits
H. pylori colonization and decreases ensuing mucosal pathology.
Results
MUC1 is shed from the epithelial cell surface into the
gastric juice and carries the Le
b,s L e
x and sLe
a
carbohydrate structures
The human gastric epithelial cell line MKN7 forms a contiguous
polarized monolayer (epithelial resistance 250 ohm/cm
2)a n d
expresses MUC1 on the apical membrane surface as occurs in
normal gastric epithelium (Figure 1A). Using double determinant
ELISA we measured MUC1 in MKN7 cells and human gastric
juice (Figure 1B), demonstrating that MUC1 is shedfrom the gastric
cell surface in vivo. MUC1 from the MKN7 cells carried the Le
b and
sLe
a oligosaccharide structures (Figure 1C, D) but not sLe
x
(Figure 1E) demonstrating that MKN7 MUC1 possesses ligands
for both the SabA and BabA H. pylori adhesins. The glycosylation of
MUC1 in gastric juice varied between individuals. Shed MUC1
from all three individuals tested carried Le
b (Figure 1C), MUC1
from one individual carried sLe
x (Figure 1E) but none of the three
gastric juice samples we investigated carried sLe
a on MUC1
(Figure 1D). This is consistent with interindividual differences in
glycosylation demonstrated for secreted gastric mucins such as
MUC5AC [11].
Author Summary
The bacterium Helicobacter pylori can cause peptic ulcer
disease, gastric adenocarcinoma and MALT lymphoma. H.
pylori colonize the mucosal surface of the stomach, where
adherence helps the bacteria to remain in the neutral and
protected niche under the mucus layer, and helps it
withstand the continuous mucus washing of the mucosal
surface. Adherence is also thought to mediate much of the
H. pylori mediated disease. The cell-surface mucin MUC1 is
highly expressed on the mucosal surface and limits the
density of H. pylori in a murine infection model. We now
demonstrate that the majority of H. pylori strains can bind
to human MUC1 and that release of MUC1 following
binding limits adhesion to the cell surface. Furthermore,
MUC1 protects the epithelium from non-MUC1 binding
bacteria by acting as a physical barrier to adhesion to
other cell surface molecules. Thus, appropriate expression
and function of MUC1 is likely to limit development of
disease ensuing from chronic H. pylori infection.
Figure 1. Expression and glycosylation of cell associated and shed MUC1. (A) Demonstration of MUC1 expression on the apical surface
(arrow) of MKN7 gastric cancer cells cultured on a transwell membrane for 3 days post confluency by staining with an anti-MUC1 cytoplasmic domain
antibody (CT2). (B–E) Cell associated and shed MUC1 was captured from the high molecular weight fraction of a cellular lysate from MKN7 cells and
from three human gastric juice samples (GJ), using a microtitre plate coated with an antibody against the extracellular domain of MUC1 (BC2). Bound
MUC1 was detected with another antibody against the extracellular domain of MUC1 (BC3) (B), and the presence of the Le
b (C), sialyl-Le
a (D) and
sialyl-Le
x (E) carbohydrate structures on MUC1 were analyzed using antibodies against these structures. Statistics: mean6SEM after subtraction of the
mean value of the isotype control coated wells for that sample.
doi:10.1371/journal.ppat.1000617.g001
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binding is dependent on H. pylori adhesins
H. pylori strains differ in their expression of the BabA and SabA
adhesins and consequently in their ability to bind to the Le
b, sLe
a
and sLe
x carbohydrate structures expressed on gastric mucins
[11,13]. The J99 wild type strain possesses both adhesins, and
bound to the adhesion ligands Le
b and sLe
x (Figure 2A). J99
bound to MUC1 isolated from the human gastric epithelial cell
line MKN7 (Figure 2B) as well as to MUC1 shed into human
gastric juice in both samples that were tested (Figure 2C), as
analyzed using a double determinant ELISA. This demonstrates
that H. pylori can bind to both cell associated and shed MUC1. In
contrast, when an isogenic J99 double mutant lacking both BabA
and SabA was used, no specific attachment of the bacteria to
MUC1 was detected (Figure 2B and C). A single J99 SabA
deletion mutant resulted in a small non-significant decrease in
MUC1 binding and a single J99 BabA deletion mutant showed
intermediate MUC1 binding (Figure 2B). This demonstrates that
binding to MUC1 occurred via MUC1 oligosaccharides bound by
both the BabA and SabA adhesins. Since the healthy stomach
normally contains a very low amount of sialylated structures,
further binding studies were performed with Le
b positive and sLe
x
negative MUC1 obtained from a healthy gastric surgical resection
specimen. The BabA positive H. pylori strains P466 and
CCUG17875/Leb also bound to MUC1, whereas the BabA
negative strains 75DBabA1/A2, CCUG17874, 26695, P1, P1-140
and M019 did not (Figure S1). Thus, non-MUC1 binding H. pylori
strains also exist. However, 80% of H. pylori strains are BabA
positive [12], and the majority of H. pylori strains thus have the
ability to bind to MUC1.
MUC1 acts as a releasable decoy for MUC1-binding
bacteria-sized beads
The demonstration that H. pylori binds to MUC1 and that
MUC1 can be shed from the epithelial surface indicated that
MUC1 could act as a releasable decoy upon bacterial adherence.
To determine whether MUC1 release can be triggered simply by
particulate binding, in the absence of microbial molecular
signalling, we used 1 mm beads coated with either an antibody
against the extracellular domain of MUC1 or with an isotype
control antibody. Immunohistochemistry of cell layers incubated
with the beads demonstrated that the MUC1-antibody-coated
beads attached to the cell surface but that they were not
endocytosed (data not shown). Adherence of beads coated with
the anti-MUC1 antibody to confluent MKN7 epithelial cells was
significantly higher at 24 h than at 4.5 h and then decreased
(Figure 3A). This pattern is consistent with a loss of beads from the
cell surface once the MUC1 binding sites on the beads are filled
and/or the MUC1 on the epithelial cell surface is depleted. The
amount of beads in the conditioned culture supernatant followed
the opposite pattern, demonstrating that the decrease of beads
attached to the cells is due to release into the supernatant rather
than bleaching of the fluorescence (Figure 3B). Furthermore, the
amount of cellular MUC1 a-subunit (extracellular domain) was
decreased in cells treated with anti-MUC1 coated beads compared
to isotype control coated beads, as demonstrated by capture
ELISA (Figure 3C). This was not due to the adherent beads
sterically hindering antibody access to MUC1 on the cell surface,
as the same decrease was shown by Western blotting of cell lysates
(Figure 3D). MUC1 was also detected in the bead-containing
conditioned media from cells treated with anti-MUC1 coated
beads, but not with isotype control coated beads (Figure 3D).
These results demonstrate that when inert bacterial sized particles
bind to MUC1, the MUC1 extracellular domain is released from
the epithelial cell surface.
Infection results in progressive depletion of cellular
MUC1 and binding of MUC1 to H. pylori
Co-cultures of confluent MKN7 cells and H. pylori were
established in microaerobic conditions at 1:1–1:20 (mammalian
cell:bacteria:) as a model of the interaction between the gastric
epithelium and H. pylori that penetrate gastric mucus. Under
microaerobic conditions the mammalian cells are not stressed and
the H. pylori survive, proliferate and show a closer physiology to
Figure 2. H. pylori binds to synthetic glycoconjugates, cell
associated MUC1 and shed MUC1 via the BabA and SabA
adhesins. Adhesion of H. pylori J99 wild type (wt), biotinylated J99wt, a
DCagA isogenic mutant and a DBabASabA isogenic double mutant to
FITC labelled Le
b or sialyl-Le
x conjugated to human serum albumin (A).
Cell associated and shed MUC1 were isolated using a microtitre plate
coated with the BC2 antibody against the extracellular domain of MUC1
(or isotype control) to capture MUC1 from the high molecular weight
fraction of a cellular lysate from the MKN7 gastric cancer cell line (B) and
from two human gastric juice samples (C), respectively. Biotinylated
J99wt (B, C) or the isogenic adhesion mutants J99DBabA (B), J99DSabA
(B) or a J99DBabADSabA double mutant (B, C), were added to the wells
where MUC1 had been captured by the anti-MUC1 antibody (or isotype
control) and binding was detected with streptavidin-HRP. Statistics:
mean6SEM after subtraction of the mean value of bacteria-only (A) or
isotype control (B-C) coated wells for that sample; ANOVA with
Bonferroni post-hoc test (B) or Students t-test (C), N=6; vs isotype
control (B,C ** p,0.01, *** p,0.001;); vs J99wt (B, ### p,0.001).
doi:10.1371/journal.ppat.1000617.g002
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The use of confluent cultures is important in modelling the gastric
epithelium to avoid H. pylori binding to the basolateral surface of
cells, as occurs with the typically used non-confluent AGS culture
system [23]. MUC1 is polarised to the apical membrane in these
MKN7 cultures (Figure 1A). After 44 h of co-culture we used flow
cytometry to measure the amount of cell surface and total MUC1
within individual viable MKN7 cells. Co-culture with the H. pylori
strain J99wt depleted MKN7 cells of approximately 40% of both
the total pool of the extracellular domain of MUC1 (Figure 4A)
and of the cell surface located extracellular domain of MUC1
(Figure 4B). To explore whether H. pylori SabA or BabA adhesin
mediated binding to MUC1 was required for depletion of MUC1
we used the J99DBabADSabA mutant as the single mutants were
able to bind MUC1 (Figure 2B). Co-culture with the double
adhesin mutant did not deplete cellular or cell surface MUC1.
These results are consistent with decreased MUC1 production,
increased degradation in the cell or release of MUC1 following
binding of the live MUC1-binding bacteria in a similar manner to
that shown with the inert 1 mm beads.
Further experiments over 1–24 h showed that the decrease in
cellular MUC1 began early in co-culture (Figure 5A; cellular
MUC1 was lower in infected cells at 1, 6, 12 and 24 h). However,
MUC1 mRNA levels increased progressively in culture but were
not significantly affected by the presence of H. pylori (Figure 5B).
The rapid decrease in MUC1 protein with sustained levels of
MUC1 mRNA, suggest that loss of protein rather than decreased
MUC1 production is the likely explanation for MUC1 depletion
from the cell. Despite the unchanged mRNA levels and the
decreasing cellular MUC1, the amount of free MUC1 in the
conditioned medium was significantly lower (by about 40%) in
infected cultures at 1, 2, 4 and 6 h (Figure 5C). Decreased MUC1
in the culture medium in infected cultures suggests that substantial
amounts of MUC1 was either bound to the bacteria (which were
removed by centrifugation prior to ELISA) and/or was degraded.
In a further experiment, total and cell surface MUC1 was assessed
by flow cytometry after 6 and 24 h of co-culture. After 6 h of co-
culture H. pylori strain J99 wt did not affect the level of MUC1 on
the cell surface, however, it led to depletion of 44% of cell surface
MUC1 after 24 h infection compared to uninfected MKN7 cells
(Figure 5D). Bacteria recovered from the culture medium were
stained for the presence of MUC1 using an antibody reactive with
the extracellular domain. MUC1 was detected bound to H. pylori
strain J99wt but not to the J99DBabADSabA mutant using both
Figure3. MUC1 is releasedfrom theepithelial surface upon adherence of MUC1-binding beads. 10
5 fluorescent beads coatedwith the BC2
antibody against the extracellular domain of MUC1 or an isotype control (IC) were added to 96 well plates with confluent MKN7 epithelial cells and
cultured for up to50 h. Bindingwas assessedafter 4.5, 24 and50 h bydetermining fluorescenceof washedmonolayers (A)andculture supernatants(B).
Statistics: Mean 6 SEM, n=9; ***p,0.001 vs 24 h. (C) The amount of MUC1 a-subunit (extracellular domain) in cells treated with anti-MUC1 coated
beadscomparedtoisotypecontrol (IC) coatedbeadswasdetected bydoubledeterminantELISAusingtheBC2 (capture) andBC3 (detection) antibodies
(***p,0.001).Westernblotting(D)was usedtodetect the MUC1extracellulardomain(usingthe BC2 antibody)incelllysates from cellstreatedwithanti-
MUC1 coated beads compared to IC for 50 h (top panel, MUC1 has an apparent mobility in the range of 280–440 kDa due to its polydisperse
glycosylation). b-actin as a loading/cell density control in the same gel is shown in the middle panel. Concentrated culture supernatants from the same
cell monolayers run on a separate SDS-PAGE/Western blot are shown in the lower panel. Origins of the gels are indicated (O).
doi:10.1371/journal.ppat.1000617.g003
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Figure S2). Binding to H. pylori strain J99wt was greatest at 6h
(Figure 5E) suggesting the bacteria may be capable of degrading or
shedding bound MUC1. Confocal microscopy showed that
MUC1 binding to bacteria was often focally intense rather than
evenly distributed on the bacterial surface (Figures 5F,G). Taken
together these data are consistent with progressive shedding of
MUC1 from the cell surface and binding of shed MUC1 to
bacteria dependent on the BabA and SabA adhesins.
MUC1 shedding is partially dependent on MMP-14
Release of MUC1 can occur either by (a) breakdown of the non-
covalent association of the a- and b-subunits, possibly in response
to shear stress or conformational changes, and/or (b) action of
extracellular proteases/sheddases. The proteases ADAM17 and
MMP-14 have previously been shown to act as MUC1 sheddases
in endometrial cells [24,25]. As both of these proteases are
expressed by MKN7 cells we repeated co-culture experiments with
and without knockdown of expression of either and both
ADAM17 and MMP-14 using siRNA. Successful knockdown of
mRNA expression of the proteases was achieved over a time
period from 8 h (Figures 6A,B) to 24 h (data not shown) after
infection. Cellular MUC1 decreased with infection at 24 h and
free MUC1 in the culture medium also decreased at 8 h which is
consistent with other experiments (presented as the proportion of
uninfected controls for all siRNA conditions in Figure 6C and D,
respectively). There were no significant alterations in the amount
of cellular MUC1 in either uninfected or infected MKN7 cells
following knockdown of ADAM 17 or MMP-14. However, there
were significant increases in the amount of shed MUC1 following
knockdown of MMP-14 at 8 but not 24 h of infection, although no
changes were seen following knockdown of ADAM17 (Figure 6D).
These data indicate that MMP-14 is partially involved in the
MUC1 shedding process in MKN7 cells.
Increased adherence of H. pylori to gastric epithelial cells
lacking MUC1
Transfection of MUC1 siRNAs into MKN7 epithelial cells
reduced cell surface MUC1 expression by 80% with the 1:1
siRNA and by 85% with the 1:3 siRNA, compared to scrambled
siRNA (Figure 7A). H. pylori J99wt, J99DCagA or J99DBabAD-
SabA (8610
5 CFU H. pylori/well) were co-cultured with confluent
transfected MKN7 monolayers for 0.5, 2, 4.5 and 20 h. While the
J99wt and J99DCagA strains bound MKN7 cells to a similar level,
binding of the J99DBabADSabA adhesin mutant was reduced at
all time points (as determined by staining the co-cultures with an
anti-H. pylori antibody, Figure 7B–E; p,0.001). After 30 min of
co-culture, binding of J99 (both with and without the SabA and
Figure 4. Cell surface MUC1 is depleted during H. pylori infection in vitro. The concentration of cellular MUC1 from non-infected MKN7 cells
and cells co-cultured with H. pylori J99 wild type or J99DBabADSabA (MOI 1:1) for 44 h was determined by flow cytometry (with the BC2 antibody) in
order to measure the amount of MUC1 per viable cell (the analysis was gated to exclude 7AAD positive dead cells) and distinguish between the total
amount of a subunit (the extracellular domain of MUC1) determined in permeabilized cells (A) and the amount of a subunit on the cell surface (B).
Representative histograms from the flow cytometry analysis are shown on the right. Median fluorescence intensity (MFI) was determined after
subtraction of the MFI using a negative control antibody. Results from 3 independent replicate cultures are shown, expressed as a percentage of the
mean MFI of cells from non-infected cultures.
doi:10.1371/journal.ppat.1000617.g004
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with H. pylori J99 wild type for 1, 2, 4, 6, 12 and 24 h (MOI 10:1) and total cellular MUC1 determined by BC2/BC3 double determinant ELISA as in
Figure 3C (A), MUC1 mRNA concentrations relative to GAPDH were determined by qPCR (B), and concentrations of free MUC1 in conditioned medium
determined by ELISA (C). In a further experiment after co-culture of MKN7 cells with H. pylori J99 wild type for 6 and 24 h cell surface MUC1 was
assessed in MKN7 cells by flow cytometry as in Figure 4B (D). In a similar experiment both the J99 wild type (MOI 10:1) and the J99DBabADSabA (20:1)
were co-cultured with MKN7 cells for 6 and 24 h and the presence of MUC1 on bacteria recovered from the conditioned media was determined by
staining with the BC2 antibody or an isotype control followed by flow cytometry (E) and confocal microscopy (F–I). For flow cytometry the MFI of the
isotype control was subtracted from the MFI of BC2-stained bacteria for each replicate culture. For confocal microscopy, H. pylori J99 wild type (F, G)
or J99DBabADSabA (H, I) were stained with BC2 (FITC-conjugated secondary antibody, green), DNA (DAPI, blue); scale bars are shown (single scans
and additional controls are shown in Figure S2). Scale bars are shown. Statistics: mean6SEM from 4 independent replicate co-cultures; Non-
parametric test (Mann Whitney); vs non-infected at same time point (A, C, D) vs J99DBabASabA (E), * p,0.05.
doi:10.1371/journal.ppat.1000617.g005
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depleted by siRNA (Figure 7B). By 2 h, and through to 20 h,
siRNA knockdown of MUC1 had no significant effect on adhesion
to the epithelial cells of the J99wt and J99DCagA strains that bind
MUC1 via the SabA and BabA adhesins (see Figure 2). In
contrast, MUC1 protection against adhesion of the J99DBabAD-
SabA strain (which did not bind MUC1, see Figure 2) to the
epithelial cells was maintained to at least 20 h. When considered
together with the changes in MUC1 expression shown in Figures 4
and 5, these results indicate that: (a) while binding via the BabA
and/or SabA adhesins increases H. pylori adhesion to gastric
epithelial cells, these bacteria can bind epithelial cells via
mechanisms other than these adhesins; (b) during early infection,
MUC1 inhibits H. pylori binding to epithelial cells occurring via
both adhesin-dependent and -independent mechanisms; (c) as
infection progresses MUC1 is depleted from the epithelial cell
surface of cells infected with H. pylori strains carrying the BabA and
SabA adhesins and is no longer effective in inhibiting attachment;
and (d) in cells that are infected with H. pylori strains that cannot
bind to MUC1, MUC1 continues to be protective against
adhesion to the epithelial cells, most likely by steric hindrance of
bacterial interactions with non-MUC1 receptors expressed on the
epithelial cell surface.
Apoptosis and necrosis is affected by H. pylori adhesion,
CagA and MUC1
To analyze cell death we used flow cytometry in combination with
annexinV/7-AAD staining which can distinguish healthy cells, cells in
early apoptosis, late apoptosis and necrosis/very late apoptosis. The
extent of H. pylori induced apoptosis in MKN7 cells was dependent on
the concentration of bacteria in the co-cultures. In MKN7 cells co-
cultured for 20 h with 6610
5 CFU/mL H. pylori (MOI 1:1), J99wt
induced 35% early apoptosis, 8% late apoptosis and 5% necrosis as
determined by annexinV/7AAD staining. J99DCagA induced similar
levels of early apoptosis, but no late apoptosis or necrosis suggesting a
delayed induction of apoptosis, while J99DBabADSabA had no affect
on the viability of MKN7 cells (Figure 8A–D, left columns). At a 10-
fold higher concentration (6610
6 H. pylori CFU/mL, MOI 10:1), all
the isogenic strains induced more apoptosis and necrosis compared
with the lower concentration of H. pylori, albeit in a similar pattern;
J99wt induced more cell death than J99DCagA, and J99DCagA
induced more cell death than J99DBabADSabA (Figure 8A–D, right
panel). Thus, both BabA/SabA mediated adhesion to the epithelial cell
and CagA contribute to epithelial cell death, but to get the maximal
effect of CagA, H. pylori needs to bind to the epithelial cell via the BabA
and SabA adhesins.
Figure 6. Shedding of MUC1 is partially dependent on the MMP-14 protease. MKN7 cells were transfected with control (scrambled),
ADAM17, MMP-14 or ADAM17 plus MMP-14 siRNA. Following 48 h of the transfection, MKN7 cells were infected with H. pylori J99 wild type or
cultured uninfected for a further 8 and 24 h. Expression of ADAM17 (A) and MMP-14 (B) mRNA relative to GAPDH was determined by qPCR in
uninfected or H. pylori J99 wild type infected cultures (8 h infection, MOI 10:1). After 8 and 24 h of infection concentrations of cellular MUC1 (C) and
free MUC1 in conditioned media (D) were determined by BC2/BC3 double determinant ELISA as in Figure 3C. MUC1 concentrations after infection are
presented as a percentage of the mean of the uninfected control for each transfection. Statistics: mean 6 SEM from 4 independent replicate co-
cultures; Nonparametric test (Mann Whitney); vs scrambled si RNA negative control (* p,0.05).
doi:10.1371/journal.ppat.1000617.g006
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cells with reduced Muc1 expression. (A) Transfection of siRNAs into
MKN7 epithelial cells reduced MUC1 expression on the cell surface by
80% with the 1:1 sequence and 85% with the 1:3 sequence compared
to scrambled siRNA as determined by flow cytometry with an
extracellular domain antibody BC2. (B–E) H. pylori J99wt, the CagA
deletion mutant J99DCagA or adhesion mutant J99DBabADSabA were
co-cultured at a concentration of 8610
5 CFU H. pylori/well (MOI 16:1) in
a 96 well plate for 0.5 (B), 2 (C), 4.5 (D) and 20 h (E). Adhesion of H. pylori
to cultured cells was determined by ELISA. Data are presented after
subtraction of the mean value of the OD for gastric cells without H.
pylori. Statistics: Mean6SEM (N=6); ANOVA, post hoc: Tukey’s test;
scrambled siRNA vs MUC1 specific siRNA * p,0.05, ** p,0.01.
doi:10.1371/journal.ppat.1000617.g007
Figure 8. H. pylori induced apoptosis and necrosis is affected by
both adhesion and CagA. MKN7 cells (Not infected; N i, left column)
co-cultured with either 6610
5 CFU/mL (MOI 1:1, middle column) or
6610
6 CFU/mL (MOI 10:1, right column) H. pylori (in 500 ml) for 20 h.
The graphs show the percentage of healthy cells, cells in early apoptosis
(Annexin-V
+, 7-AAD
2), late apoptosis (Annexin-V
+, 7-AAD
+ cells) and
necrosis (Annexin-V
2, 7-AAD
+ cells) analyzed by flow cytometry.
Statistics: Mean 6 SD from 3 independent replicate co-cultures; Mann
Whitney U test, vs non-infected * p,0.05.
doi:10.1371/journal.ppat.1000617.g008
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pylori induced apoptosis, transfection of siRNAs into MKN7 cells
reduced MUC1 levels by 93% and 97% with the 1:1 and 1:3
sequences respectively, compared to scrambled siRNA. Cultures
with depleted MUC1 had fewer healthy cells and more apoptotic
cells, irrespective of whether or not they were infected (Figure 9A–
D). However, the proportion of necrotic cells was slightly lower in
the cells with reduced MUC1.
Finally, to ascertain whether MUC1/Muc1 can also influence
H. pylori induced epithelial apoptosis in vivo we analysed apoptosis
in wild-type (Muc1
+/+) and Muc1
2/2 mice infected with H. pylori-
SS1 as previously described [20]. While no difference was
observed 1 week post-infection, Muc1
2/2 mice had a 3-fold
increase in the mean proportion of TUNEL-positive apoptotic
cells in their gastric mucosa after 8 weeks of H. pylori infection,
compared to Muc1
+/+ mice (Figures 9E and S3). Thus, MUC1/
Muc1 protects against apoptosis both in vitro and in a murine H.
pylori infection model.
Discussion
Previously we have shown that mice deficient in Muc1 are more
susceptible to infection by H. pylori [20] both with regard to the
level of colonisation and the degree of pathology that develops. We
have now extended these observations by examining the
mechanism by which this mucin can limit infection by H. pylori.
Here we demonstrate that MUC1 protects the epithelial cell from
both bacterial adhesion and apoptosis. When the pathogen does
not bind to MUC1, the 200–500 nm long extracellular domain of
the mucin appears capable of physically distancing the bacteria
from the host cell surface, thus sterically inhibiting adhesion to
other potential cell surface ligands. When the pathogen does bind
to MUC1, the extracellular domain of the mucin is released from
the epithelial surface, thereby acting as a releasable decoy and
preventing prolonged adherence. In the process H. pylori are
coated with MUC1 via, as we demonstrate here, interactions
between the mucin and the BabA and SabA adhesins. We propose
that this would further prevent anchorage to the mucosal surface
by blocking these key adhesins. Limiting attachment of the
bacteria to the epithelial surface would also be expected to reduce
pathogenicity, by restricting the functional activity of secretion
systems such as that encoded by the Cag pathogenicity island,
which delivers proinflammatory mediators into epithelial cells
[26].
An isogenic CagA deletion mutant induced less cell death in the
polarized MKN7 cultures we established in microaerophilic
conditions, consistent with previous studies in other cell lines
[27]. However, in our experiments which are the first to test the
influence of SabA and BabA adhesins on apoptosis empirically,
ablation of both adhesins had a substantially greater impact on H.
pylori induced apoptosis than loss of CagA. Thus, both adhesion to
the epithelial cell and CagA affect viability, but to get the maximal
effect of CagA, H. pylori needs to bind to the epithelial cell via the
lectin adhesins. Interestingly, at very high non-physiological
bacterial infection densities, similar to those used by most
researchers, these nuances were lost. Infection with BabA positive
H. pylori strains has been associated with higher lymphocytic
infiltration, increased epithelial proliferation, and the presence of
glandular atrophy and intestinal metaplasia in human antral
biopsies [28]. Similarly, severe neutrophil infiltration and atrophy
(important indicators of more severe pathology) are associated
with the expression of functional SabA [29]. Here, we showed that
H. pylori induces apoptosis and necrosis in gastric epithelial cells in
a dose dependent manner, and that an isogenic mutant strain
Figure 9. Gastric epithelial cell apoptosis and necrosis is
affected by MUC1/Muc1. (A–D) MKN7 transfected with MUC1 siRNAs
1:1, 1:3 (97 and 93% knockdown compared to scrambled siRNA) and
scrambled siRNA were co-cultured with 3610
5 H. pylori/well (500 mL, MOI
1:1) for 20 h (A–D). The graphs show (A) the percentage of healthy cells,
(B) cells in early apoptosis (Annexin-V
+, 7-AAD
2), (C) late apoptosis
(Annexin-V
+, 7-AAD
+ cells), and (D) necrosis (Annexin-V
2, 7-AAD
+ cells),
analyzed by flow cytometry. Data were collected for three independent
replicate co-cultures and are presented as mean6SD. (E) Six wild-type
(Muc1
+/+) and Muc1
2/2 mice were infected with H. pylori-SS1 as
previously described [20]. The number of TUNEL positive cells per 10
random fields of view in the gastric mucosa was counted at 206
magnification. Statistics: bar=mean, Mann Whitney U test, * p,0.05.
Photomicrographs of the TUNEL stained sections are shown in Figure S3.
doi:10.1371/journal.ppat.1000617.g009
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induce cell death. This indicates that these adhesins are major
determinants of cell surface binding and that it is the amount of
adherent H. pylori that determines the impact on epithelial cell
viability.
To inhibit bacterial access to the epithelial cells, the mucosal
surfaces are covered with a mucus layer primarily composed of
secreted mucins. This mucus layer is continuously secreted and
transports away trapped material. Both salivary and gastric mucins
have a high and specific binding capacity for H. pylori [9,10,11],
and it is likely that this mucus layer keeps the majority of H. pylori
away from the epithelial cell surface. For example, in the human-
like rhesus monkey model [30], monkeys secreting mucins with less
H. pylori binding capacity develop higher H. pylori density infections
and gastritis [14]. Similarly, humans with primary Sjogren’s
syndrome, who produce less mucins, have more H. pylori-
associated pathology [31], suggesting that the ability of secreted
mucins to bind to H. pylori protects the gastric epithelium. In
cultured MKN7 cells we observed a progressive depletion of
MUC1 as it was shed off the cell surface. In human patients with
chronic gastritis, depletion of the MUC1 extracellular domain a-
subunit, but not the transmembrane b-subunit, has been reported
[32]. Thus, it is likely that during chronic infection rapid shedding
of the extracellular domain of MUC1 occurs in vivo, producing a
similar result to that we observed in vitro.
We have shown that H. pylori adherence to live gastric epithelial
cells is increased when the bacterial strain carries the BabA and
SabA adhesins. However, adherence to live epithelial cells occurs
even when these adhesins are absent, albeit to a reduced level. In
contrast, binding to MUC1, as we have shown previously for other
mucins [10,11], is dependent on the presence of H. pylori adhesins.
During the initial contact with gastric cells, MUC1 inhibits
adhesion of both MUC1-binding and non MUC1-binding H. pylori
to epithelial cells. H. pylori bind to MUC1 isolated from epithelial
cells as well as to MUC1 shed into the gastric juice of human
patients. In this study we have shown that, in vitro, H. pylori carrying
these adhesins caused the gastric epithelial cells to shed MUC1
which bound to the bacteria. Inert bacterial sized beads coated
with MUC1 antibodies also caused shedding of MUC1,
demonstrating that MUC1 can act as a releasable decoy following
engagement by particulate ligands in a Toll like receptor
independent manner. Our demonstration of progressive depletion
of cellular MUC1 is consistent with a previous study where MUC1
expression decreased in Kato III cells after 4 h of co-culture with
H. pylori (with unknown adhesion properties) [33]. Although the
study with Kato III cells showed recovery of MUC1 after 24 h of
co-culture, the recovery of MUC1 may be because this study
added 1000-fold higher concentrations of H. pylori than used in our
study, and their H. pylori died during the experiment according to
the authors possibly due to the use of aerobic culture conditions
[22,33,34].
We have demonstrated that MMP-14 but not ADAM17 is the
relevant protease involved in the endogenous shedding of MUC1
from MKN7 cells. This is consistent with previous reports that
found that MUC1 shedding was sensitive to MMP-14 depletion in
endometrial cells [24]. However, MMP-14 only partially affected
MUC1 shedding during infection and had no influence on MUC1
shedding in non-infected cells, indicating that other factors are
involved in MUC1 release. Although cleavage by another
unknown MUC1 sheddase cannot be definitively excluded, the
most likely scenario is disassociation of the non-covalent
interaction between the transmembrane and extracellular domains
at the SEA module, a site of cleavage during synthesis found in
most cell surface mucins [35,36]. Disassociation could occur due to
conformational changes in MUC1 following binding or due to
shear forces following binding to the highly motile bacteria.
Additionally, secreted isoforms of MUC1 expressed via alternative
splicing [37], could potentially be shed without prior H. pylori
binding and contribute to the MUC1 pool in the mucus and
gastric juice. The pattern of focal binding of MUC1 to bacteria
that we observed by confocal microscopy is consistent with binding
of MUC1 to regions of the bacteria coming in contact with the cell
surface, followed by MUC1 shedding and bacterial detachment.
However, this pattern could also arise if the SabA and BabA
adhesins are focally expressed or if they are aggregated on the
bacterial surface following ligation by MUC1.
MUC1 confers resistance to apoptosis induced by genotoxic
drugs, the Campylobacter jejuni cytolethal distending toxin and
oxidative stress in vitro [21,38]. We found that Muc1
2/2 mice
infected with H. pylori strain SS1 had substantially more apoptotic
cells in their gastric mucosa than Muc1
+/+ mice. In vitro, cultures
with MUC1 knockdown had a higher proportion of apoptotic
cells, both when infected and not infected, indicating that
epithelial cell apoptosis is down regulated by MUC1 as a general
function, not only as a response to stressors. Paradoxically,
however, necrosis was lower in cells with reduced MUC1. A
similar increase of damage induced apoptosis and delay of
secondary necrosis has previously been described for mono(-
ADP-ribosyl)transferases, which control signal transduction path-
ways in response to cell damage during cell repair and apoptosis
[39]. MUC1 increases ß-catenin levels in the cytoplasm and nuclei
of carcinoma cells by blocking its degradation, resulting in an
increase in cell proliferation [40,41]. Similarly, NF-kB regulates
genes that control cell proliferation and cell survival, and NF-kBi s
constitutively active in some cancers. MUC1 interacts directly with
the IkB kinase complex, resulting in degradation of the NF-kB
inhibitor IkBa [42]. Thus, high expression of MUC1, as occurs in
the stomach and is commonly found in human cancers, confers
increased proliferation and resistance to apoptosis both via ß-
catenin and the NF-kB pathway. NF-kB is also the master
regulator of inflammatory responses, including responses to H.
pylori. In addition to a possible effect on NF-kB, it is possible that
MUC1 modulates responses to PAMPs mediated by TLRs. In
respiratory cells, MUC1 binding of bacterial flagellin (TLR5
ligand) appears to repress TLR5-mediated activation of inflam-
mation [43,44]. Thus, in addition to limiting bacterial attachment
to the cell surface, MUC1 may modulate inflammatory responses
possibly limiting unnecessary responses when bacteria fail to stably
bind to the cell surface. Further work is required to fully define the
influence of MUC1 on epithelial cell responses to the presence of
H. pylori.
Human population studies have found associations between
MUC1 allele polymorphisms and susceptibility to the development
of gastric adenocarcinoma and H. pylori-associated gastritis
[18,19]. VNTR length polymorphisms have been used to
characterize these alleles and short VNTR alleles which encode
MUC1 proteins with shorter extracellular glycosylated domains
are associated with disease. Our data are consistent with the
interpretation that shorter forms of MUC1 are less efficient at
sterically inhibiting attachment or acting as releasable decoys,
thereby allowing increased bacterial binding to the epithelial
surface and exacerbation of pathology. Experiments where cells
were transfected with MUC1 expressing differing VNTR lengths
suggest that longer alleles are more efficient at binding H. pylori
[45]. However, it is possible that these VNTR length polymor-
phisms are surrogate markers for SNP’s encoding functional
changes in other domains (for example, SNPs affecting cytoplas-
mic domain signaling or cleavage of the extracellular domain) or
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during infection. More comprehensive genetic epidemiological
studies are warranted to further define the nature of the MUC1 risk
alleles.
Our experiments show that MUC1 inhibits the H. pylori binding
to epithelial cells that occurs via both the BabA and SabA adhesins
and non-adhesin mediated binding. When the pathogen does not
bind to MUC1, the mucin sterically inhibits adhesion to other
potential cell surface ligands. When the pathogen does bind to
MUC1, the extracellular domain of the mucin is released from the
epithelial surface, thereby acting as a releasable decoy and
preventing prolonged adherence. Demonstration of the mecha-
nism by which MUC1 limits gastric H. pylori infection is a model
paradigm for elucidation of the function of the family of cell
surface mucins which decorate the apical membrane surface of all
mucosal epithelial cells, and for exploration of their contribution to
preventing infectious and inflammatory disease.
Materials and Methods
Ethics statement
The collection of gastric juice was obtained after written
informed consent from patients undergoing upper gastrointestinal
endoscopy (approved by the Mater Health Services’ Human
Research Ethics Committee, Approval No. 396A). All procedures
involving animals were reviewed and approved by Institutional
animal care and use committees (University of Melbourne; AEEC
No. 03219)
Immunohistochemistry
Dewaxed and rehydrated formalin-fixed sections (4 mm) were
treated with 10 mM citric acid, pH 6 at 100uC for 20 min and
then with 3% (v/v) hydrogen peroxide for 30 min at room
temperature. The sections were washed 3 times between all
subsequent steps in 0.15 M NaCl, 0.1 M Tris/HCl buffer (pH 7.4)
containing 0.05% Tween-20. Non-specific binding was blocked by
protein block (Dako) for 30 min. The sections were incubated with
an anti-MUC1 antibody (CT2, gift from Prof. S. Gendler,
Scottsdale, USA) diluted 1:50 in Antibody Diluent (Dako) for
1 h, then incubated with Broad Spectrum Poly HRP Conjugate
(Zymed Laboratories Inc, San Fransisco, USA) for 10 min and
with diaminobenzidine for 10 min. The sections were counter-
stained with Harris’s haematoxylin.
MUC1 antibodies
Three antibodies against MUC1 were used in this study: The
CT2 antibody is against the cytoplasmic tail of MUC1, whereas
the BC2 and BC3 antibodies are against the extracellular domain
of MUC1, and react with a VNTR repeat epitope that is exposed
even in fully glycosylated MUC1 [46]. These antibodies all react
with mature glycosylated MUC1 on the apical surface of human
gastric epithelium [46].
Isolation of MUC1 and assessment of MUC1 glycosylation
Gastric juice was obtained after informed consent from patients
undergoing upper gastrointestinal endoscopy. The gastric juice
was adjusted to pH 7 with Tris and mixed with equal volume of
150 mmol/L NaCl, 1% NP40, 0.5% deoxycholic acid, 0.1% SDS,
50 mmol/L Tris, pH 7.5 containing Complete protease inhibitor
(Roche Diagnostics GmbH, Mannheim, Germany) (RIPA buffer)
and incubated for 5 min under agitation at 4uC, centrifuged at
10,000 g for 10 min at 4uC and the supernatant used for the
binding assays. Cells from the gastric cancer cell line MKN7
(Riken, Japan) were lysed in RIPA buffer for 10 min under
agitation at 4uC, lysates centrifuged at 10,000 g for 10 min at 4uC
and the high molecular weight fraction purified from the
supernatant using a Microcon centrifugal filter device (cut off
100 kDa). Microtitre plates (Polysorb, Nunc, Denmark) were
coated overnight at 4uC with either the BC2 antibody or the
isotype control antibody 401.21 against a-gliadin (100 mL/well,
4 mg/mL in phosphate-buffered saline, PBS). The plates were then
washed 3 times in PBS with 0.05% Tween-20 and unbound sites
blocked with 1% BSA in PBS for 1 h at room temperature. The
wells were then incubated with cell lysate or gastric juice extract
diluted 1:5 in Blocking reagent for ELISA (Boehringer Mannheim,
Germany) containing 0.5% BSA and 0.05% Tween-20 (dilution
buffer) for 2 h with orbital shaking, washed as above, incubated
with primary antibody: anti-MUC1 (clone BC3), anti-Le
b (clone
LE2, Biotest, Dreieich, Germany), anti-sialyl-Le
a (clone CA19-9,
NeoMarkers, Freemony, CA, USA) or anti-sialyl-Le
x (AM3, gift
from Dr C. Hanski, University Medical Center Charite, Berlin,
Germany) diluted to 1 mg/mL, 1:200, 1:1000 and 1:20, respec-
tively. The plates were washed and incubated with HRP-
conjugated anti-mouse IgM (Jackson ImmunoResearch Labora-
tories, Inc, USA). HRP activity was determined using 2,29-
Azinobis(3-ethylbenzothiazoline)-6-sulphonic acid as a substrate
(0.550 g/L in citrate phosphate buffer pH 4.3) by measuring
absorbance at 405 nm. Assays were performed in triplicate.
H. pylori adherence to glycoconjugates
H. pylori were harvested and washed twice by centrifugation at
2,500 g in PBS containing 0.05% Tween-20. 100 ml H. pylori
(OD600 nm=0.90) was incubated with 500 ng FITC labelled Le
b
or sialyl-Le
x HSA-conjugates for 30 min in PBS containing 0.5%
human albumin and 0.05% Tween-20. Fluorescence was
measured after washing the bacteria twice. Assays were performed
in triplicate.
MUC1 bacterial binding assays
Binding of H. pylori to MUC1 was determined by sandwich
ELISA using biotinylated bacteria. Polysorb Microtitre plates
(Nunc, Denmark) were coated overnight at 4uC with either the
BC2 antibody against the extracellular domain of human MUC1,
or the isotype control antibody 401.21 (100 mL/well, 4 mg/mL in
PBS). The plates were then washed 3 times in PBS with 0.05%
Tween-20 and unbound sites blocked with 1% BSA in PBS for 1 h
at room temperature. The wells were then incubated with cell
lysate or gastric juice extract diluted 1:5 in Blocking reagent for
ELISA (Boehringer Mannheim, Germany) containing 0.5% BSA
and 0.05% Tween-20 (dilution buffer) for 2 h with orbital shaking,
washed as above, then incubated with a suspension of biotinylated
SS1, J99wt or J99DBabA/SabA (OD600=0.15 diluted 1:10 in
dilution buffer) for 2 h at 37uC with orbital shaking. The plates
were washed and incubated with streptavidin-HRP (diluted 1:1000
in dilution buffer) for 1 h at room temperature and HRP activity
determined as above. To get a sufficient amount of MUC1 to
analyze binding with a range of H. pylori strains, archived purified
mucins from a previously published study on tissue from patients
with no history of peptic ulcer disease undergoing elective surgery
for morbid obesity was used [11]. MUC1 was isolated from whole
gastric wall using isopycnic density gradient centrifugation
followed by gel chromatography of the mucin containing fractions
to separate MUC1 from the oligomeric mucins as previously
described [9], and analyzed by ELISA [9].
Cell culture
The gastric epithelial cell line MKN7 (Riken Cell Bank, Japan)
was cultured in RPMI containing 10% FCS, 2 mM L-glutamine,
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Mucin expression and glycosylation in this cell line has been
described previously [22]. For co-culture with H. pylori the medium
was changed to antibiotic free medium 20 h prior to infection.
The co-culture experiments were performed on confluent MKN7
cells transferred to microaerobic conditions (5% O2, 15% CO2,
80% N2) at the start of the co-culture. MKN7 cell viability is not
compromised during these conditions [22], and the microaerobic
conditions are similar to the actual pO2 and pCO2 in tissues of the
human body [47].
To assess integrity of monolayer cultures MKN7 cells were
cultured on snapwell tissue culture inserts, which were then were
mounted in vertical Ussing chambers (exposed area 1.13 cm
2).
The basolateral side of the membrane was immersed in 115.8 mM
NaCl, 1.3 mM CaCl2, 3.6 mM KCl, 1.4 mM KH2PO4, 23.1 mM
NaHCO3, 1.2 mM MgSO4 (KREB) solution containing 5.7 mM
Na-pyruvate, 5.1 mM Na-L-glutamate 10 mM and D-glucose,
whereas the apical compartment was immersed in KREB’s
solution containing 5.7 mM Na-pyruvate, 5.13 mM Na-L-gluta-
mate and 10 mM D-mannitol. The solutions were gassed with
95% O2 and 5% CO2 at a temperature of 37uC and pH 7.4
throughout the whole experiment. Epithelial resistance (Rp) was
measured using square-pulse analysis. 5 V, 3 ms pulses were
generated by a square pulse generator (Medimet, Gothenburg,
Sweden) via a current limiting resistor (36 kV) connected to a
platinum electrode and applied across the sample.
H. pylori culture
H. pylori were grown on Brucella agar supplemented with 10%
bovine blood, 2% Vitox (Oxoid), 10 mg/mL vancomycin (Sigma),
5 mg/mL trimethoprim (Sigma) and 4 mg/mL amphoteracin B
(Sigma) for 4 days in 5% O2 and 15% CO2 at 37uC. H. pylori
strains J99 wild type (wt) bind Le
b and sialyl-Le
x, CCUG17875/
Leb and P466 bind Le
b but not sialyl-Le
x, the 17875BabA1::-
kanbabA2::cam-mutant (75DbabA1A2) and CCUG17874, bind
sialyl-Le
x but not Le
b, whereas the remaining strains; the isogenic
J99 adhesion mutant lacking the BabA and SabA adhesins
(J99babA::camsabA::kan [13], referred to as J99DBabADSabA),
26695, P1 and P1-140 do not bind sialyl-Le
x or Le
b [11] (provided
by Prof. Thomas Boren, Umea ˚ University, Sweden). The J99
CagA deletion mutant (J99DCagA) was made by natural
transformation with a plasmid containing the cloned CagA from
strain 26695 that was knocked out by insertion of the CatGC
cassette into the singular Bg/II site in the middle of the cagA gene
(provided by Prof Steffen Backert, Institut fur Medizinische
Microbioligie, Magdeburg, Germany). Clones were selected after
culture on 6 mg chloroamphenicol/mL agar. Disruption of CagA
was verified by PCR using the 59-AAAGGATTGTCCCTACAA-
GAAGC-39 and 59-GTAAGCGATTGCTCTTGCATC seque-
nces. The concentration of H. pylori was estimated by measuring
OD600, and then the amount of CFU in the inoculum was
determined by counting colonies from serial dilutions cultured for
5 days. The Multiplicity Of Infection (MOI, pathogen:host cell)
was determined based on the CFU of the H. pylori and a density of
1.5610
5 MKN7 cells/cm
2 cells at the day of confluency, which is
the day we infected the cells.
Biotinylation of H. pylori
The bacteria were washed twice in 0.2 mol/L carbonate buffer
pH 8.3 (2610
9 bacteria/mL), 125 mg/mL biotin-XX-NHS was
added and the mixture rotated in the dark for 15 min at room
temperature. To verify that the BabA adhesin remained
functional, adherence to the Le
b conjugate was measured
(Figure 2).
Assessment of bead binding to gastric epithelial cells
10
5 fluorescent beads (Fluospheres NeutrAvidin labelled 1 mm
microspheres, Molecular probes) coated with an antibody against
the extracellular domain of MUC1 (BC2 antibody) or isotype
control (401.21) were added to 96 well plates with confluent
MKN7 epithelial cells (N=9). After incubation for 4.5 h, 24 h and
44 h, cultures were washed 3 times with ice cold PBS and
fluorescence was quantified in a FLA5100 (Fujifilm).
SDS-PAGE and Western blotting
RIPA lysates were subjected to SDS-PAGE in a 4–12%
gradient gel. Western blots were cut in the middle (,70 kDa)
and the upper half was stained with an antibody against the
MUC1 extracellular domain (BC2) and the lower half was probed
for b-actin and detected with fluorescent probes on the Licor
Odyssey instrument.
RNA preparation and real-time PCR
Total RNA was prepared using the RNeasy Mini Kit (Qiagen,
Valencia, CA, USA). The quantity and quality of the RNA was
determined by spectrophotometry (ND-1000; NanoDrop Tech-
nologies Inc., Wilmington, DE). Total RNA (1 mg) from each
sample was used for first strand cDNA synthesis using Super-
Script
TM III reverse transcriptase (Invitrogen) following the
manufacturer’s instructions. Real-time PCR was monitored by
SYBRH Green I fluorescence (Invitrogen) using Platinum H Taq
DNA-Polymerase (Invitrogen) with 3 mM MgCl2, 0.2 mM prim-
ers, 200 mM dNTPs, and 0.5 U polymerase per reaction (25 ml)
under primer-specific conditions. The following experimental
protocol for PCR reaction (40 cycles) was performed on a
Rotor-Gene 3000 cycler (Corbett Research, Sydney, Australia):
denaturation for 15 min at 95uC, followed by 40 amplification
cycles at 94uC (20 s), annealing under primer-specific conditions
(30 s), and extension for 45 s at 72uC. Primers with the following
sequences were chosen: GAPDH: forward: 59- CCTGTACGC-
CAACACAGTGC -39, reverse: 59- ATACTCCTGCTTGCT-
GATCC -39, annealing temperature 60uC. MUC1: forward: 59-
CCCCTATGAGAAGGTTTCTGC-39, reverse: 59- ACCTG-
AGTGGAGTGGAATGG -39, annealing temperature 60uC.
ADAM-17: forward: 59-ACCTGAAGAGCTTGTTCATCGAG
-39, reverse: 59-CCATGAAGTGTTCCGATAGATGTC-39, an-
nealing temperature 60uC. MMP-14: forward: 59-CCATCA-
TGGCACCCTTTTACC-39 reverse: 59-TTATCAGGAACA-
GAAGGCCGG-39; annealing temperature 60uC. All Primers
were obtained from GeneWorks (Hindmarsh, SA, Australia). To
confirm the specificity of the amplified DNA, a melting curve was
determined at the end of each run. The reaction efficiency was
determined with a dilution series of cDNA containing the PCR
products. Genes were normalized to the unregulated housekeeping
gene GAPDH and the results were expressed as ratio of target
gene and GAPDH expression (arbitrary units). Control experi-
ments were also performed to ensure that GAPDH expression was
not differentially regulated under the experimental conditions
employed.
ADAM 17 and MMP-14 gene silencing in MKN7 cells with
siRNA
>siRNA specific for ADAM17 and MMP-14 as well as scrambled
siRNA were chemically synthesized (Dharmacon Research, Lafayette,
USA) as a mixture of four siRNAs targeting different regions of the
same gene to enhance the silencing performance (21 mers, SMART-
pool). MKN 7 cells with a confluence of 70–80% were transfected
with either 250 nM of ADAM17 siRNA or MMP 14 siRNA
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Reagent (Invitrogen) according to the manufacturer’s instructions.
250 nM or 500 nM of scrambled control siRNA were used as
negative control. After 48 h of transfection, the MKN7 cells were co-
cultured with Hp y l o r iJ99 wild type for a further 8 and 24 h, and the
uninfected MKN 7 cells were also cultured for a further 8 and 24 h as
a negative control. The MKN7 cells were harvested after 56 and 72 h
transfection, the level of knockdown of the ADAM 17 or MMP-14
was detected by quantitative RT-PCR, and the influence of the
treatment on MUC1 shedding was monitored by ELISA.
MUC1 knockdown by siRNA transfection
100 nM 29-hydroxyl DsiRNA against the target sequence
NNGUUCAGUGCCCAGCUCUAC (1:1) and NNGCACCGA-
CUACUACCAAGA (1:3) or siCONTROL non-targeted siRNA#2
(Dharmacon) were transfected into MKN7 cells using Lipofectamine
2000. Four days after transfection the level of knockdown was
measured using the medianfluorescence intensitydetermined byflow
cytometry (below). The 1:3 siRNA generally gave higher knockdown
than the 1:1 siRNA.
Flow cytometry
Cell viability was analysed by collecting non-adherent cells
together with attached cells harvested with trypsin and counting cell
suspensions by flow cytometry on cells stained with 1 mg/mL 7-
aminoactinomycin D (7AAD) and Annexin-V-PE Apoptosis Detec-
tion Kit I (BD Pharmingen) according to the manufacturers
instructions. For MUC1 detection, cells harvested with trypsin and
stained with 1 mg/mL 7AAD were either stained without fixation
(staining of cell surface structures) or fixed in 1% paraformaldehyde
for 5 min on ice and then permeabilized with 0.5% saponin
(intracellular and extracellular staining). The cells were then
incubated with the anti-MUC1 antibody BC2 or isotype control
401.21 at 3 mg/mL in 1% BSA in PBS for 60 min at 4uCa n dt h e n
with anti-mouse antibody conjugated to Alexa fluor 488 (Invitrogen).
For detection of intracellular antigens, washes and antibody
incubations were performed in the presence of 0.5% saponin. After
staining, all cells were fixed with 1% paraformaldehyde. The analysis
was gated to exclude 7AAD positive cells and assessment of staining
was performed on a LSRII Flow Cytometer (BD Biosciences, San
Jose, USA) using the Diva software (BD Biosciences, San Jose, USA).
Bacteria were recovered from the culture medium of MKN7 cells by
first sedimenting non-adherent mammalian cells (300 g, 5 min) and
then sedimenting bacteria (5000 g, 10 min). Bacteria were then
stained with BC2 or 401.21 at 10 mg/mL as above and gated using
the SSC and FSC pattern of broth cultured H. pylori.
Assessment of MUC1 binding to H. pylori by confocal
microscopy
Bacteria prepared and stained for flow cytometry as above were
smeared onto charged glass slides, stained with DAPI (0.1 mg/ml)
for 15 min, washed with PBS, mounted in Prolong Gold
(Invitrogen) and examined using a Zeiss LSM510 confocal
microscope with multitracking detecting DAPI (excitation
405 nm, detection 420–480 nm) and FITC (excitation 488 nm
detection, LP 505 nm) fluorescence separately.
Assessment of H. pylori binding to gastric epithelial cells
H. pylori J99wt, the J99DCagA or J99DBabADSabA were co-
cultured at a concentration of 8610
5 CFU H. pylori/well in a 96
well plate. Co-cultures were washed 3 times with ice cold PBS and
then fixed with 4% paraformaldehyde for 20 min on ice. After
washing, wells were blocked for 1 h with 1% BSA in PBS and then
incubated with mouse polyclonal anti-Helicobacter antisera [20].
The plates were washed and incubated with HRP-conjugated anti-
mouse IgG (Jackson ImmunoResearch Laboratories, Inc, USA).
The plates were washed and HRP activity determined using TMB
by measuring absorbance at 450 nm.
Experimental animals and procedures
All procedures involving animals were reviewed and approved
by Institutional animal care and use committees (University of
Melbourne; AEEC No. 03219). The mouse infection tissue
samples were archived material from a previously published study
[20]. Female aged matched 129/SvJ wild type and 129/SvJ
Muc1
2/2 mice were infected intra-gastrically once with 10
7 H
pylori suspended in 0.1 mL Brain Heart Infusion (Oxoid).
TUNEL assay
The assay was performed according to the manufacturer’s
instructions (Roche), except that the reaction was diluted 1:4 in
0.1 M sodium cacodylate buffer, pH 7.3 to decrease the
background. The total number of TUNEL positive cells per 10
randomly selected fields of view in the entire gastric mucosa was
counted at 206magnification.
Statistics
For normally distributed data the Students t-test was used to
compare groups. For analyses where a normal distribution could
not be demonstrated, including where the number of replicates
was low, the non-parametric Mann Whitney U test was used to
compare groups. The ANOVA test was used when comparing 3 or
more groups, and to ascertain that the multiple testing did not add
to the chance of finding statistically significant differences, the
Tukey’s or Bonferroni’s post hoc tests were used.
Supporting Information
Figure S1 MUC1 binding of additional H. pylori strains. H. pylori
adhesion to Le
b positive, sLe
x negative MUC1 isolated from a
healthy gastric specimen. MUC1 was isolated using isopychnic
density gradient centrifugation followed by gel chromatograpy of
the mucin containing fractions to separate MUC1 from the
oligomeric mucins as previously described [9], and analyzed by
ELISA [9]. CCUG17875/Leb and P466 bind Le
b but not sialyl-
Le
x, the 75DbabA1A2 and CCUG17874, bind sialyl-Le
x but not
Le
b, whereas the remaining strains 26695, P1 and its isogenic
mutant P1-140 does not bind neither sialyl-Le
x nor Le
b [11]. Data
are presented as Mean 6 SEM binding to the 4 fractions
containing MUC1 after subtraction of the mean value of the
control wells (bacteria binding to non-mucin containing fractions
from the gel chromatogaphy) for that H. pylori strain.
Found at: doi:10.1371/journal.ppat.1000617.s001 (0.17 MB TIF)
Figure S2 Confocal microscopy images of MUC1 binding to H.
pylori which were recovered from the culture medium of MKN7
cells after 8 h of co-culture. H. pylori J99 wild type (A–C) or
J99DBabADSabA (D, E) were either stained with MUC1
extracellular domain antibody BC2 (A, B, D and E) or an isotope
control antibody 401.21 (C), followed by a FITC-conjugated
secondary antibody (green), and DNA stained with DAPI (blue).
Scale bars are shown.
Found at: doi:10.1371/journal.ppat.1000617.s002 (1.32 MB PDF)
Figure S3 Photomicrographs of Tunel stained sections. Tunel
stained sections from stomach of wild-type (Muc1
+/+) and Muc1
2/2
mice infected with H. pylori-SS1 for 1 week vs 8 weeks.
Found at: doi:10.1371/journal.ppat.1000617.s003 (9.84 MB TIF)
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